Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/29/16  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Paul F. McKenzie

Wrong Dr. Paul F. McKenzie?

Vice President Research and Devel...

Phone: (610) ***-****  
Email: p***@***.com
Local Address:  Radnor , Pennsylvania , United States
Johnson & Johnson
One Johnson & Johnson Plz
New Brunswick , New Jersey 08933
United States

Company Description: Johnson & Johnson manufactures and sells of a broad range of products in the health care field. It conducts business in virtually all countries. The Company's...   more

Employment History

Board Memberships and Affiliations


  • Ph.D. , Chemical Engineering
    Carnegie Mellon University
  • B.S. , Chemical Engineering
    University of Pennsylvania
67 Total References
Web References
Thank You For Making the Users Conference Another Success, 23 May 2013 [cached]
Paul McKenzie, VP of Manufacturing Technology for Johnson & Johnson (who introduced us all to the term "homosapien-based data integration," which we heard used several more times during the week!); Scott Key, President of IHS; and Caterpillar's David Krenek shared their stories of how the Connected Supply Chain is driving the need for a more connected data infrastructure.
 Panel Participants (from left to right) Johan Krebbers, Shell Group, Paul McKenzie, Janssen Pharmaceuticals, and Scott Key, IHS, discuss the importance of data in the connected supply chain in San Francisco, CA.
2013 - Users Conference - San Francisco, 1 Jan 2013 [cached]
Paul will share his vision on the challenges of sharing data and how the PI System and PI Exchange Services helps Johnson & Johnson gain unprecedented visibility into a complicated supply chain. Janssen Supply Chain (JSC) supervises global supply chain management for Johnson & Johnson's Pharmaceuticals business unit, which requires managing a complex of internal and external networks. He will describe how JSC meets the infrastructure challenges to manufacturing high quality pharmaceuticals.
Paul McKenzie
As the Vice President of Manufacturing and Technical Operations (MTO) for Janssen Supply Chain (JSC), Paul McKenzie, Ph.D. leads the JSC internal manufacturing and External Supply Integration (ESI) functions within the JSC. Under Paul's leadership the manufacturing organization is clearly prioritizing JSC's reliability and technical initiatives across the internal and external network - leveraging resources where appropriate and ensuring equal emphasis on assets in terms of quality, service and cost. In addition to internal and external manufacturing, the Environmental Health & Safety, Sustainability and Crucell functions also report into Paul. Paul joined Johnson & Johnson in 2008 as the Head of Bio-Pharmaceutical Development & Manufacturing Support where he was responsible for end-to-end technical support for both the development and commercial portfolio for Centocor. In 2009, he assumed responsibility for a newly formed group, Pharmaceutical Development and Manufacturing Sciences (PDMS), which was accountable to develop, commercialize and support new molecular entities across their entire product lifecycle for both small and large molecules. In his most recent role as Head of the Global Development Organization of Janssen Pharmaceutical Companies, Paul was responsible for driving value creation and increasing R&D operational effectiveness across clinical development operations, pharmaceutical development, clinical pharmacology and drug safety sciences. Through close interactions with the therapeutic and functional area leaders, as well as with supply chain and external partners, Paul's team contributed to the development and successful approval of life changing medicines to patients around the world. Prior to Johnson & Johnson, Paul worked for Bristol-Myers Squibb as Vice President and General Manager of the large-scale cell culture facility, as well as Vice President, Technical Transfer Governance Committee. Prior to BMS, Paul worked for Merck in various roles with the company's large-scale organic pilot plant and Pharmaceutical Development & Clinical Supply pilot plants. Paul is a graduate of the University of Pennsylvania (B.S. in Chemical Engineering) and Carnegie Mellon University (Ph.D. in Chemical Engineering). He is currently a member of the Board of Trustees of Illinois Institute of Technology and the Board of the Society for Biological Engineering. He has served on numerous professional and academic boards. In his spare time, Paul enjoys supporting his children in their academic and athletic pursuits. All of his kids enjoy competitive swimming and that has led Paul to become certified as a YMCA and USA swimming coach and official. Paul still competes himself in both masters swimming and water polo. When not at a pool for a swim meet, Paul and his family enjoy spending the summer weekends with their extended family at the New Jersey coast.
AZ Corporation > Boston ISPE 2006, 1 Jan 2006 [cached]
This year's keynote address was provided by Dr Paul McKenzie, VP & Devens Site Manager for Bristol-Myers Squibb.
Research Triangle Park, NC (5 February ..., 5 Feb 2007 [cached]
Research Triangle Park, NC (5 February 2007) - WBF has announced that Dr. Paul McKenzie, Vice President and General Manager - LSCC at Bristol Myers Squibb, and Walter Boyes, Editor-in-Chief at CONTROL Magazine, will give keynote addresses at the WBF 2007 North American Conference.
Dr. McKenzie's keynote address, entitled "ISA-88 - It's Not Just for Batch Anymore," will give an overview of the Bristol Myers Squibb systems in pharmaceutical development.Topics will include the BMS Pharmaceutical Development road map for laboratory systems, quality systems, and process control.McKenzie will also discuss achieving harmonization, focusing on consistent facility capabilities, standard procedures approach, and reduced/shared documentation.
The address will give attendees more information on standardizing equipment, operations and data collection, and creating a seamless link with SAP for management of materials.Dr. McKenzie will share his insights on "plug-n-play" analytical instrumentation, real time batch reporting, modeling and implications for technology transfer, ISA-88 and the laboratory, and bottom-line results.
Dr. McKenzie is currently Vice President & General Manager of LSCC, Technical Operations, in the Worldwide Medicines Group of Bristol Myers Squibb Company.In this role, he is responsible for the design, construction and start-up of the new biologics plant in Devens, Massachusetts.
Previously, McKenzie was Vice President, Technology Transfer, in the Worldwide Medicines Group of Bristol-Myers Squibb Company.He, along with his colleagues, created and oversaw the business processes for technology transfer of fermentation, chemical, biologic and drug product processes for new drug candidates from the Pharmaceutical Research Institute to Manufacturing.
SBE Leadership | SBE, 11 Feb 2015 [cached]
Dr. Paul McKenzie, Johnson & Johnson
Other People with the name "McKenzie":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.